Difficulty: Medium
Average Score: 91%
Practice
66-year-old female with a long history of heavy smoking presents to her doctor with complaints of shortness of breath and chronic coughing that has been present for about 2 years: and has been worsening in frequency. The doctor decides to prescribe a bronchodilator agent that has minimal cardiac side effects, since the patient also has an extensive cardiac history. Which medication did the doctor likely prescribe?
Correct answer
D
Rationale
The likely medication the doctor prescribed for the 66-year-old female with a history of heavy smoking and cardiac issues is D) Ipratropium. Ipratropium is an anticholinergic bronchodilator that primarily acts on the peripheral nervous system to dilate the bronchial airways, making it easier for the patient to breathe. It is preferred in patients with cardiac issues because it has minimal cardiac side effects compared to other options.
A) Albuterol is a beta-agonist bronchodilator that can cause cardiac side effects such as tachycardia, which may be concerning for a patient with a cardiac history.
B) Prazosin is an alpha-blocker primarily used for hypertension and not indicated for bronchodilation.
C) Atenolol is a beta-blocker that can worsen bronchoconstriction in patients with respiratory issues like chronic obstructive pulmonary disease (COPD).
Educationally, understanding the pharmacological properties of medications used in respiratory conditions is crucial for healthcare providers to make appropriate treatment decisions tailored to each patient's unique medical history and needs. This case highlights the importance of selecting bronchodilators with minimal cardiac side effects in patients with both respiratory and cardiac comorbidities.
A) Albuterol is a beta-agonist bronchodilator that can cause cardiac side effects such as tachycardia, which may be concerning for a patient with a cardiac history.
B) Prazosin is an alpha-blocker primarily used for hypertension and not indicated for bronchodilation.
C) Atenolol is a beta-blocker that can worsen bronchoconstriction in patients with respiratory issues like chronic obstructive pulmonary disease (COPD).
Educationally, understanding the pharmacological properties of medications used in respiratory conditions is crucial for healthcare providers to make appropriate treatment decisions tailored to each patient's unique medical history and needs. This case highlights the importance of selecting bronchodilators with minimal cardiac side effects in patients with both respiratory and cardiac comorbidities.